Orange Book product · Generic (ANDA)
TRETINOIN
TRETINOIN
At a glance
Oct 11, 2012
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 11, 2012
13 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
TRETINOIN
Strength
0.075%
Dosage form
CREAM
Route
TOPICAL
TE code
Not listed
Application
ANDA 202209
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of TRETINOIN
- 2018ALTRENOBrand (NDA)
NDA 209353 · DOW PHARM
- 2007ATRALINBrand (NDA)
NDA 022070 · DOW PHARM
- 2002RETIN-A MICROBrand (NDA)
NDA 020475 · BAUSCH
- 2000RENOVABrand (NDA)
NDA 021108 · VALEANT PHARMS NORTH
- 1998AVITABrand (NDA)
NDA 020400 · RISING
- 1997AVITABrand (NDA)
NDA 020404 · MYLAN PHARMS INC
- 1995RENOVABrand (NDA)
NDA 019963 · VALEANT PHARMS NORTH
- 1995VESANOIDBrand (NDA)
NDA 020438 · CHEPLAPHARM
- 1988RETIN-ABrand (NDA)
NDA 019049 · BAUSCH
- —RETIN-ABrand (NDA)
NDA 017522 · VALEANT BERMUDA
- —RETIN-ABrand (NDA)
NDA 017340 · VALEANT PHARMS NORTH
- —RETIN-ABrand (NDA)
NDA 017955 · BAUSCH
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
